Whispering Gallery Modes (WGM) for label free bioanalytics
The status, timeline and source of this project. A free account opens every field.
Source: EU Funding & Tenders Portal
The latest industry research shows that about 90 percent of drugs that reach clinical stage fail due to incorrect selection methods. The same applies to diagnostic markers. A crucial failure source is the imperfect identification and characterisation of biological interaction analytics in the early stages of drug discovery and biomarker identification. Surflay's innovation addresses this challenge
- Status
- Closed
- Location
- Germany
- Updated
- 22 Jul 2026
- Source
- EU Funding & Tenders Portal
ConstructChat
Ask ConstructChat about Whispering Gallery Modes (WGM) for label free bioanalytics
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | ended |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | The latest industry research shows that about 90 percent of drugs that reach clinical stage fail due to incorrect selection methods. The same applies to diagnostic markers. A crucial failure source is the imperfect identification and characterisation of biological interaction analytics in the early stages of drug discovery and biomarker identification. Surflay's innovation addresses this challenge. The company developed the unique WhisperSense technology based on the physical effect of whispering gallery modes (WGM). WhisperSense makes a full kinetic analysis of biological interations possible, uniquely applying a spatial resolution of up to 6 µm in complex biological matrixes (e.g. cell culture suspensions), also in a multiplex format. Furthermore and uniquely, it is possible to perform measurements in a wide variety of reaction vessels. For the first time, WhisperSense will allow full kinetic analyses within cell cultures and organoids. All these advances eliminate certain time consuming sample preparation steps at the customer's site and enable monitoring of running processes in real-time, leading to a more precise drug and biomarker selection. The development is protected by 3 patents and many years of expert knowledge in the production of the special spherical microparticles. Initially, Surflay will address the public sector with its WhisperSense technology, followed by the diagnostic and pharmaceutical industry. |
Location
Country | Germany |
Source
Source | EU Funding & Tenders Portal |
URL |
More Details
Record type | Project |
Article published date | 2026-02-01 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More infrastructure projects in Germany
- Veja Mate Offshore Wind Farm Project
- Albatros Offshore Wind Farm North Sea Germany
- Hohe See Offshore Wind Farm North Sea Germany
- EnBW Baltic 2 Offshore Wind Farm
- Herdecke 400MW CCGT GasFired Power Plant Grenada
- Global Tech I Offshore Wind Farm
- Nordsee One Offshore Wind Project North Sea
- Westfalen Power Plant Units D and E Hamm
